| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2d6c63af05648054f8699926d62bcce |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-71 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2012-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_943587e438d42b81eb35e4f1fb9be2e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1262ac103f77d0bd92fa881ad90e8a33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2b630a42d9578e9b7534f87e5a9b697
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4531bf076cbc0330742b4e4146a4fbd |
| publicationDate |
2014-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2993668-A1 |
| titleOfInvention |
THERANOSTIC METHOD BASED ON THE DETECTION OF HER2-HER2 DIMERS |
| abstract |
The present invention relates to an ex vivo method for determining the susceptibility of a patient suffering from a cancer to respond to a therapeutic treatment based on the administration of an antibody specific for the HER2 protein, this method comprising the quantification of dimers HER2-HER2 in a tissue sample of said patient using the FRET technique. The invention also relates to a reagent kit for the implementation of this method. |
| priorityDate |
2012-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |